Inari Medical Inc (NARI) - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US45332Y1091
Inari Medical, Inc. (NASDAQ: NARI) is a company based in Irvine, California, that specializes in developing innovative, minimally invasive catheter-based technologies for specific medical conditions in the United States.
Their flagship products, ClotTriever and FlowTriever, are designed to effectively remove large blood clots from major vessels, aiding in the treatment of conditions such as deep vein thrombosis, pulmonary embolism, and other complex venous thromboembolism cases.
Catering to interventional radiologists, interventional cardiologists, and vascular surgeons, Inari Medical, Inc. was founded in 2011, initially operating under the name Inceptus Newco1 Inc. before rebranding to its current identity in September 2013. To learn more about their cutting-edge technologies, visit their website at https://www.inarimedical.com.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
NARI Stock Overview
| Market Cap in USD | 2,453m |
| Sector | Healthcare |
| Industry | Medical Devices |
| GiC SubIndustry | Health Care Equipment |
| TER | 0.00% |
| IPO / Inception | 2020-05-22 |
NARI Stock Ratings
| Growth 5y | -2.06 |
| Fundamental | 0.49 |
| Dividend | - |
| Rel. Performance vs Sector | -5.62 |
| Analysts | 4.40/5 |
| Fair Price Momentum | 32.99 USD |
| Fair Price DCF | 11.82 USD |
NARI Dividends
| Yield 12m | 0.00% |
| Yield on Cost 5y | 0.00% |
| Dividends CAGR 5y | 0.00% |
| Payout Consistency | 0.0% |
NARI Growth Ratios
| Growth 12m | -42.10% |
| Growth Correlation 12m | -40% |
| Growth Correlation 3m | -52% |
| CAGR 5y | -2.41% |
| Sharpe Ratio 12m | -0.84 |
| Alpha vs SP500 12m | -73.22 |
| Beta vs SP500 5y weekly | 1.45 |
| ValueRay RSI | 12.49 |
| Volatility GJR Garch 1y | 52.53% |
| Price / SMA 50 | -18.57% |
| Price / SMA 200 | -33.08% |
| Current Volume | 796.8k |
| Average Volume 20d | 1618.3k |
External Links for NARI Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X (Twitter) • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of April 19, 2024, the stock is trading at USD 38.64 with a total of 796,790 shares traded.
Over the past week, the price has changed by -6.94%, over one month by -7.18%, over three months by -33.40% and over the past year by -39.57%.
According to ValueRays Forecast Model, NARI Inari Medical Inc will be worth about 37.2 in April 2025. The stock is currently trading at 38.64. This means that the stock has a potential downside of -3.75%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 74.3 | 92.2% |
| Analysts Target Price | 83.1 | 115.1% |
| ValueRay Target Price | 37.2 | -3.75% |